Mortality of People with Parkinson's Disease in a Large UK‐Based Cohort Study: Time Trends and Relationship to Disease Duration
Open Access
- 5 August 2021
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 36 (12) , 2811-2820
Abstract
Background: Parkinson's disease (PD) is associated with increased mortality, but little is known about changes over time, and relationship to disease progression.Objectives: To explore how PD mortality rates have changed over time and their relationship to disease duration and demographics using a large population‐based cohort in the UK.Methods: We included individuals aged 50+ years with a first recording of PD diagnosis and at least two prescriptions of any antiparkinsonian drug actively registered within a general practice from 2006 to 2016 and up to six frequency‐matched controls from The Health Improvement Network (THIN) database. We estimated adjusted mortality rates using multivariable Poisson regression.Results: A total of 10,104 people with a diagnosis of PD and 55,664 people without PD were included. Overall, PD was associated with slightly increased mortality compared to non‐PD controls (adjusted mortality rate ratio: 1.14; 95% CI: 1.03 to 1.19). Adjusted mortality rates per 1000 person‐years at risk for people with PD approximately doubled in the 5 years following diagnosis from 43 (95% CI: 38 to 48) to 75 (95% CI: 64 to 85). Following adjustments for age, gender, and time since diagnosis, mortality rates between 2007 and 2016 declined more slowly for people with PD (2% per year; 95% CI: 0%–4%) compared to people without PD (5% per year; 95% CI: 3%–6%).Conclusions: Whilst mortality in PD is only slightly increased overall, it gradually increases with advancing disease. There has been a decline in mortality in PD over time, but this decrease was less pronounced than that in the general population. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.Keywords
This publication has 50 references indexed in Scilit:
- Validation of The Health Improvement Network (THIN) primary care database for monitoring prescriptions for smoking cessation medicationsPharmacoepidemiology and Drug Safety, 2010
- Trends in Parkinson’s disease related mortality in England and Wales, 1993–2006European Journal of Neurology, 2009
- Creating medical and drug code lists to identify cases in primary care databasesPharmacoepidemiology and Drug Safety, 2009
- Incidence and remaining lifetime risk of Parkinson disease in advanced ageNeurology, 2009
- Validation studies of the health improvement network (THIN) database for pharmacoepidemiology researchPharmacoepidemiology and Drug Safety, 2006
- The relationship between time since registration and measured incidence rates in the General Practice Research DatabasePharmacoepidemiology and Drug Safety, 2005
- Mortality in Parkinson's disease and its association with dementia and depressionActa Neurologica Scandinavica, 2004
- Survival time, mortality, and cause of death in elderly patients with Parkinson's disease. A 9‐year follow‐upMovement Disorders, 2003
- Mortality from Parkinson's disease in England and Wales 1921-89.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Parkinson's disease in Aberdeen: survival after 3.5 yearsActa Neurologica Scandinavica, 1990